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Specific cell-mediated immunity (CMI) responses to rubella virus were studied
in 12 children with documented congenital rubella syndrome employing a 51Cr
lymphocytotoxicity microassay. Hemagglutination inhibition antibody was de-
tected in 11 of the 12 children, with titers ranging from 1:4 to 1: 128. CMI to
rubella virus was demonstrated in only 3 of the 11 antibody-positive children.
The 12th child was negative for both hemagglutination inhibition and CMI. Of
the three children with a positive CMI response, two had histories of reinfection
with rubella virus. These data suggest that congenital rubella infection produces
an impaired CMI response which subsequently may be altered by reinfection
with rubella virus. The lack of CMI in the presence of antibody and concurrent
excretion of live virus in the child with documented congenital rubella infection
suggest a factor to be explored in the pathogenesis of this disease.
Studies of infants with congenital rubella
syndrome indicate that high titers of virus can
be isolated from the throat, urine, and various
tissues in the presence of fetal and maternal
antibodies (1, 7, 10, 22). This has led a number
of investigators to postulate that a defect exists
in the cellular immune responsiveness of these
infants. Moreover, in infants with congenital
rubella, histological evidence of damage to
lymphoid tissue including the thymus has been
reported (18). Rubella virus has also been iso-
lated from thymus tissue and circulating small
lymphocytes (3, 16). Conflicting results with
cellular immune studies have been reported. An
almost complete lack of response of lympho-
cytes to phytohemagglutinin (PHA) stimula-
tion, in the presence of typical delayed hyper-
sensitivity skin reactions, has been observed
with these infants (8, 9). Other investigators,
however, have achieved stimulation of lympho-
cytes with PHA (6, 15, 23).
We have previously described a specific mi-
croassay procedure for the measurement of
cell-mediated immunity (CMI) to rubella virus
(20). In this investigation, this assay was em-
ployed to study CMI to rubella in children with
congenital rubella.
MATERIALS AND METHODS
Study cases. Eleven children and one 5-month-old
infant with documented congenital rubella were in-
cluded in the study group (Table 1). Most of the
children, ranging in age from 7 to 14 years were
afflicted during the 1964-65 rubella epidemic. All
were enrolled in a special education program for the
physically handicapped. Consent from the parents
was procured for collection of blood, urine, and
nasopharyngeal swabs. Clinical information was ob-
tained from the parents, the private physicians, and
from hospital records after our immunological studies.
For positive controls, serum and lymphocytes were
collected from 8- and 12-year-old children with histo-
ries of rubella immunization and an adult with a
history of rubella infection. An infant with no history
of rubella immunization or natural infection served as
negative control.
Viral isolations. Urine or nasopharyngeal swabs,
or both, were obtained from most of the children.
Isolation attempts for rubella were performed in
African green monkey kidney cell culture by using the
enterovirus interference technique previously de-
scribed (13).
Immunological studies. Approximately 10.0 ml of
blood was collected by venous puncture from all cases
in the study. Three milliliters of blood was immedi-
ately transferred to a sterile tube containing 300 U of
heparin for separation of lymphocytes. The remaining
blood (7.0 ml) was transferred to an empty tube and
allowed to clot for separation of serum, which was
tested for hemagglutination inhibition antibodies
(HAI) by a method previously described (14).
Microassay of CMI. Measurement of CMI to
rubella was accomplished by employing a microassay
procedure (20). This technique used cells persistently
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infected with rubella virus and was labeled with 51Cr.
The release of 5'Cr from these rubella virus-infected
target cells was the indicator; it permitted quantita-
tion of lymphocyte-mediated cytotoxicity. Briefly,
lymphocytes were first separated from whole blood by
using a Hypaque-Ficoll separation gradient. They
were then washed and resuspended to a concentration
of 5 x 106 viable lymphocytes per ml. A suspension
culture of cell line MA 66182 (21) (BHK-21 cells
persistently infected with rubella virus) was labeled
with 5'Cr by incubation of 107 cells with 100 MCi of
chromium in 1.0 ml of media for 30 min. Control cells
of uninfected BHK-21 cells were also labeled with 51Cr
and used to determine nonspecific lymphocyte-
mediated cytotoxicity. Samples (0.1 ml) of the lym-
phocytes (5 x 10" cells) were incubated with 5 x 103
labeled target cells in sterile plastic plates and were
placed on a rocker platform at 37 C in a 5% CO2
atmosphere. The cell suspensions were harvested after
18 and 24 h of incubation with an apparatus designed
to separate the reacting cells from the supernatant
fluid and to recover the released 5'Cr. To determine
lymphocyte-mediated cytotoxicity directed specifi-
cally against intracellular rubella virus, spontaneous
release of 56Cr from infected target cells (I) and
control cells (C) was subtracted from the interaction
of lymphocytes with infected target cells (IL) as well
as control cells (CL), respectively, and the release at
zero time was subtracted from the total amount of
radioactivity in infected (T,) and control (Ta) target
cells. The specific immune release (SIR) was calcu-
lated by subtracting the percentage of 51Cr release in
the control target cells from that released from the
infected cells according to the following formula:
% SIR =
I[ C -C 100
Ti - zero time, T, - zero time,
All determinations were made in sextuplicate, and
the highest SIR at either 18- or 24-h intervals was used
as the index of CMI to rubella. Values for SIR of less
than 4.0% were considered to be negative determina-
tions.
RESULTS
Results of the study appear in Table 1. For 11
of the 12 children with congenital rubella, HAI
antibodies ranging in titer from a trace at 1:4 to
a maximum of 1: 128 were detected. Specific
cellular immune responses to rubella virus were
demonstrated in three children (K.M., D.D.,
J.McD.). Two of these children had histories of
reinfection. There was no apparent relationship
between age, antibody titer, and SIR. CMI to
rubella was not demonstrated in all other sub-
jects, including a 5-month-old infant who was
still excreting virus in the presence of antibody.
PHA stimulation studies were performed on the
lymphocytes of this infant using a dose-response
test. Stimulation occurred, and the response
was comparable with that observed with control
lymphocytes from immune donors. The PHA
stimulation studies were not done on the lym-
phocytes of the other 11 children.
DISCUSSION
The microassay lymphocytotoxicity system
permits the measurement of the specific cellular
immune response to rubella virus (20). The
results of the present studies provide direct
evidence that there is a lack of cellular immu-
nity to rubella virus after intrauterine infection.
These findings may provide an explanation for
the apparent delayed capability of congenitally
infected infants to overcome the infection in
early post-partum period. It is also possible that
fetuses which are immunologically incompetent
for cellular immune functions at the time of
infection are those born affected with rubella
syndrome (17). Additional studies on infants
still excreting virus in the presence of humoral
antibody will be required to determine whether
elimination of virus coincides with development
of cellular immunity. It is possible that a
temporary CMI response does occur in these
cases. If this is not found, then termination of
infection would most likely relate to the final
death of infected cells (12). Further studies
would be required to determine the effects of
transferring immunocompetent cells or transfer
factor during the newborn period to determine if
this would limit viral persistence in the new-
born.
A variety of immune responses after congeni-
tal infection with rubella has been studied. The
best-known example is the elevation of globu-
lins at or shortly after birth occurring as a result
of intrauterine infection. Conversely, congenital
infection with rubella virus may also retard or
change the development of the humoral re-
sponses. Hypogammaglobulinemia and selec-
tive immunoglobulin deficiencies have been
reported (5, 11, 19). In addition, defects in
specific antibody production to rubella virus
have also been described (19). In the present
study, the loss of HAI antibody titer in two
children is in agreement with previously re-
ported studies showing declining antibody titers
with increasing age in cases of congenital ru-
bella (4). Since recent evidence suggests a
helper function of T-lymphocytes to humoral
antibody production, it is possible that a loss of
antibody in these children could be the result of
the loss or impairment of T-cell function against
rubella (2). Studies of both the humoral and
cellular immune responses in congenital rubel-
la-infected children after administration of vac-
cine may help further to define the extent of
impairment in immunity.
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TABLE 1. Clinical data and immunologic studies for 12 children with the congenital rubella syndrome
History of rubella rein- Rubella HAI Rubella -"Cr Rubella isolation
Subject Age (yrs) Sex fection or rubella antibody titera SIR (%)
immunization Throat Urine
Patient
L.B. 8 F None < 4 0 _b
J.G. 8 M None 8 0 - NDc
A.D. 8 M None 8 0 ND ND
B.S. 5/12 F None 32 0 + ND
R.M. 8 M None 32 0.7 - ND
B.N. 7 M None -4 1.1 - ND
A.K. 8 F None 16 3.5 - ND
S.S. 8 F Rubella vaccine 10 0 - -
F.S. 8 F ?Rubella at age 7 32 0 - -
K.M. 7 F None 128 13.6 - -
D.D. 14 M Rubella during early 128 18.0 - -
childhood
J.McD. 11 F Rubella at age 7 32 40.3 - ND
Control
Negative 8/12 M None < 4 0
Positive 8 M Rubella vaccine 16 12.3
Positive 12 M Rubella vaccine 32 17.6
Positive 32 M Rubella infection 128 48.7
a Reciprocal of last dilution manifesting positive reaction.
Negative, no virus isolated.
c ND, Not done.
The normal PHA response of the one infant
(B.S.) still excreting virus indicates that rubella
infection does not impair the reactivity of pe-
ripheral lymphocytes to a nonspecific mitogen
and possibly other viral antigenic stimuli. Also,
the lack of a cellular response to rubella during
this period of infection while antibody levels are
high suggests that impairment of immune re-
sponse is limited to mechanisms of cellular
immunity alone.
Our data suggest that CMI to rubella virus
may be stimulated or reactivated, since two
children in this study had normal CMI re-
sponses presumably as a result of reinfection
with rubella later in life. One child (S.S.) had a
negative CMI to rubella but previously had
received the rubella vaccine. This would indi-
cate that vaccine is not an effective stimulant of
CMI in the presence of antibody.
Finally, the lack of cellular immunity in
congenital rubella syndrome as demonstrated in
the present studies may provide an explanation
for the establishment and persistence of viral
excretion in other congenital, chronic, or slow
viral infections of man.
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